Notification Works News Today

The regulations, changing the language, that that scares off their investors. these are small start-up companies, some of them, and there are just numerous complaints about the regulatory review process. and the other question is, why couldnt this have been done six months ago? >> i think the actions that the fda is taking have been under way for some time. this enhances their visibility, but for anyone to suggest that this current generic, injectable drug shortage has to do with barriers really...